John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 99,940 shares at $149.15 ($14.9M) on 2024-04-10, disclosed to the SEC on 2024-04-11.
Scheduled sale ($14.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.28 | 542 | $83K | 0.6% |
| 2 | $152.28 | 542 | $83K | 0.6% |
| 3 | $153.47 | 2,734 | $420K | 2.8% |
| 4 | $153.47 | 2,734 | $420K | 2.8% |
| 5 | $154.21 | 7,924 | $1.2M | 8.2% |
| 6 | $154.21 | 7,924 |
| $1.2M |
| 8.2% |
| 7 | $148.40 | 11,514 | $1.7M | 11.4% |
| 8 | $148.40 | 11,514 | $1.7M | 11.4% |
| 9 | $149.15 | 12,501 | $1.9M | 12.5% |
| 10 | $149.15 | 12,501 | $1.9M | 12.5% |
| 11 | $149.79 | 2,641 | $396K | 2.6% |
| 12 | $149.79 | 2,641 | $396K | 2.6% |
| 13 | $150.85 | 60 | $9K | 0.1% |
| 14 | $146.09 | 5,008 | $732K | 4.9% |
| 15 | $146.09 | 5,008 | $732K | 4.9% |
| 16 | $146.82 | 4,265 | $626K | 4.2% |
| 17 | $146.82 | 4,265 | $626K | 4.2% |
| 18 | $147.74 | 2,811 | $415K | 2.8% |
| 19 | $147.74 | 2,811 | $415K | 2.8% |
| Total | $149.50 avg | 99,940 | $14.9M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |